{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:32:55Z","timestamp":1794612775618,"version":"4.9.1"},"reference-count":167,"publisher":"Springer Science and Business Media LLC","issue":"6","license":[{"start":{"date-parts":[[2018,4,6]],"date-time":"2018-04-06T00:00:00Z","timestamp":1522972800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Nat Rev Nephrol"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1038\/s41581-018-0003-9","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T10:02:39Z","timestamp":1523613759000},"page":"378-393","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":191,"title":["Advances in predictive in vitro models of drug-induced nephrotoxicity"],"prefix":"10.1038","volume":"14","author":[{"given":"Joanne Y.-C.","family":"Soo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jitske","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1560-1074","authenticated-orcid":false,"given":"Rosalinde","family":"Masereeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa H.","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,4,6]]},"reference":[{"key":"3_CR1","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1007\/978-3-642-00663-0_5","volume-title":"Adverse Drug Reactions","author":"TD Nolin","year":"2010","unstructured":"Nolin, T. D. & Himmelfarb, J. in Adverse Drug Reactions (ed. Uetrecht, J.) 111\u2013130 (Springer, Berlin, Heidelberg, 2010)."},{"key":"3_CR2","doi-asserted-by":"publisher","first-page":"270","DOI":"10.1038\/nrneph.2009.43","volume":"5","author":"J-P Gr\u00fcnfeld","year":"2009","unstructured":"Gr\u00fcnfeld, J.-P. & Rossier, B. C. Lithium nephrotoxicity revisited. Nat. Rev. Nephrol. 5, 270\u2013276 (2009).","journal-title":"Nat. Rev. Nephrol."},{"key":"3_CR3","doi-asserted-by":"publisher","first-page":"193","DOI":"10.1038\/nrneph.2013.282","volume":"10","author":"O Rewa","year":"2014","unstructured":"Rewa, O. & Bagshaw, S. M. Acute kidney injury \u2014 epidemiology, outcomes and economics. Nat. Rev. Nephrol. 10, 193\u2013207 (2014).","journal-title":"Nat. Rev. Nephrol."},{"key":"3_CR4","doi-asserted-by":"publisher","first-page":"5079","DOI":"10.1021\/jm400416u","volume":"56","author":"TV Magee","year":"2013","unstructured":"Magee, T. V. et al. Discovery of Dap-3 polymyxin analogues for the treatment of multidrug-resistant Gram-negative nosocomial infections. J. Med. Chem. 56, 5079\u20135093 (2013).","journal-title":"J. Med. Chem."},{"key":"3_CR5","doi-asserted-by":"publisher","first-page":"1933","DOI":"10.1021\/mp400720w","volume":"11","author":"HY Tiong","year":"2014","unstructured":"Tiong, H. Y. et al. Drug-induced nephrotoxicity: clinical impact and preclinical in vitro models. Mol. Pharm 11, 1933\u20131948 (2014).","journal-title":"Mol. Pharm"},{"key":"3_CR6","doi-asserted-by":"publisher","DOI":"10.1002\/prp2.148","volume":"3","author":"JX Huang","year":"2015","unstructured":"Huang, J. X. et al. Evaluation of biomarkers for in vitro prediction of drug-induced nephrotoxicity: comparison of HK-2, immortalized human proximal tubule epithelial, and primary cultures of human proximal tubular cells. Pharmacol. Res. Perspect. 3, e00148 (2015).","journal-title":"Pharmacol. Res. Perspect."},{"key":"3_CR7","doi-asserted-by":"publisher","first-page":"309","DOI":"10.3109\/10408449609012526","volume":"26","author":"W Dekant","year":"1996","unstructured":"Dekant, W. & Vamvakas, S. Biotransformation and membrane transport in nephrotoxicity. Crit. Rev. Toxicol. 26, 309\u2013334 (1996).","journal-title":"Crit. Rev. Toxicol."},{"key":"3_CR8","doi-asserted-by":"crossref","unstructured":"Hawksworth, G. M. et al. in Toxicology \u2014 From Cells to Man (eds Seiler, S. P., Kroftov\u00e1, O. & Eybl, V.) 184\u2013192 (Springer, Berlin, Heidelberg, 1996).","DOI":"10.1007\/978-3-642-61105-6_19"},{"key":"3_CR9","doi-asserted-by":"publisher","first-page":"18","DOI":"10.1177\/019262339802600102","volume":"26","author":"EA Lock","year":"1998","unstructured":"Lock, E. A. & Reed, C. J. Xenobiotic metabolizing enzymes of the kidney. Toxicol. Pathol. 26, 18\u201325 (1998).","journal-title":"Toxicol. Pathol."},{"key":"3_CR10","doi-asserted-by":"publisher","first-page":"758","DOI":"10.1021\/mp500590s","volume":"12","author":"N Knops","year":"2015","unstructured":"Knops, N. et al. The functional implications of common genetic variation in CYP3A5 and ABCB1 in human proximal tubule cells. Mol. Pharm. 12, 758\u2013768 (2015).","journal-title":"Mol. Pharm."},{"key":"3_CR11","doi-asserted-by":"publisher","first-page":"629","DOI":"10.1038\/nrneph.2017.107","volume":"13","author":"P Bhargava","year":"2017","unstructured":"Bhargava, P. & Schnellmann, R. G. Mitochondrial energetics in the kidney. Nat. Rev. Nephrol. 13, 629\u2013646 (2017).","journal-title":"Nat. Rev. Nephrol."},{"key":"3_CR12","doi-asserted-by":"publisher","first-page":"1924","DOI":"10.1681\/ASN.2013101121","volume":"25","author":"R Kramann","year":"2014","unstructured":"Kramann, R., Tanaka, M. & Humphreys, B. D. Fluorescence microangiography for quantitative assessment of peritubular capillary changes after AKI in mice. J. Am. Soc. Nephrol. 25, 1924\u20131931 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR13","doi-asserted-by":"publisher","first-page":"155","DOI":"10.1111\/j.1440-1797.2007.00779.x","volume":"12","author":"W Qi","year":"2007","unstructured":"Qi, W., Johnson, D. W., Vesey, D. A., Pollock, C. A. & Chen, X. Isolation, propagation and characterization of primary tubule cell culture from human kidney (Methods in Renal Research). Nephrology 12, 155\u2013159 (2007).","journal-title":"Nephrology"},{"key":"3_CR14","doi-asserted-by":"publisher","first-page":"395","DOI":"10.1517\/17425255.2014.876990","volume":"10","author":"P Fisel","year":"2014","unstructured":"Fisel, P., Renner, O., Nies, A. T., Schwab, M. & Schaeffeler, E. Solute carrier transporter and drug-related nephrotoxicity: the impact of proximal tubule cell models for preclinical research. Expert Opin. Drug Metab. Toxicol. 10, 395\u2013408 (2014).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"3_CR15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1007\/s00253-005-1955-9","volume":"68","author":"A Lemke","year":"2005","unstructured":"Lemke, A., Kiderlen, A. F. & Kayser, O. Amphotericin, B. Appl. Microbiol. Biotechnol. 68, 151\u2013162 (2005).","journal-title":"Appl. Microbiol. Biotechnol."},{"key":"3_CR16","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1016\/j.pharmthera.2017.06.009","volume":"180","author":"C Mamoulakis","year":"2017","unstructured":"Mamoulakis, C. et al. Contrast-induced nephropathy: Basic concepts, pathophysiological implications and prevention strategies. Pharmacol. Ther. 180, 99\u2013112 (2017).","journal-title":"Pharmacol. Ther."},{"key":"3_CR17","doi-asserted-by":"publisher","first-page":"94","DOI":"10.1111\/his.13064","volume":"70","author":"P Paueksakon","year":"2017","unstructured":"Paueksakon, P. & Fogo, A. B. Drug-induced nephropathies. Histopathology 70, 94\u2013108 (2017).","journal-title":"Histopathology"},{"key":"3_CR18","doi-asserted-by":"publisher","first-page":"1385","DOI":"10.1038\/ki.2008.356","volume":"74","author":"MA Perazella","year":"2008","unstructured":"Perazella, M. A. & Markowitz, G. S. Bisphosphonate nephrotoxicity. Kidney Int. 74, 1385\u20131393 (2008).","journal-title":"Kidney Int."},{"key":"3_CR19","doi-asserted-by":"publisher","first-page":"F1307","DOI":"10.1152\/ajprenal.00046.2009","volume":"296","author":"L Xia","year":"2009","unstructured":"Xia, L., Zhou, M., Kalhorn, T. F., Ho, H. T. B. & Wang, J. Podocyte-specific expression of organic cation transporter PMAT: implication in puromycin aminonucleoside nephrotoxicity. Am. J. Physiol.-Ren. Physiol. 296, F1307\u2013F1313 (2009).","journal-title":"Am. J. Physiol.-Ren. Physiol."},{"key":"3_CR20","doi-asserted-by":"publisher","first-page":"2059","DOI":"10.1007\/s00198-011-1836-2","volume":"23","author":"M Yilmaz","year":"2012","unstructured":"Yilmaz, M., Taninmis, H., Kara, E., Ozagari, A. & Unsal, A. Nephrotic syndrome after oral bisphosphonate (alendronate) administration in a patient with osteoporosis. Osteoporos. Int. 23, 2059\u20132062 (2012).","journal-title":"Osteoporos. Int."},{"key":"3_CR21","doi-asserted-by":"publisher","first-page":"1795","DOI":"10.2174\/1381612053764922","volume":"11","author":"HF Cheng","year":"2005","unstructured":"Cheng, H. F. & Harris, R. C. Renal effects of non-steroidal anti-inflammatory drugs and selective cyclooxygenase-2 inhibitors. Curr. Pharm. Des. 11, 1795\u20131804 (2005).","journal-title":"Curr. Pharm. Des."},{"key":"3_CR22","doi-asserted-by":"publisher","first-page":"349","DOI":"10.1097\/00000441-200306000-00006","volume":"325","author":"MA Perazella","year":"2003","unstructured":"Perazella, M. A. Drug-induced renal failure: update on new medications and unique mechanisms of nephrotoxicity. Am. J. Med. Sci. 325, 349\u2013362 (2003).","journal-title":"Am. J. Med. Sci."},{"key":"3_CR23","doi-asserted-by":"publisher","first-page":"F887","DOI":"10.1152\/ajprenal.00050.2001","volume":"281","author":"DP Basile","year":"2001","unstructured":"Basile, D. P., Donohoe, D., Roethe, K. & Osborn, J. L. Renal ischemic injury results in permanent damage to peritubular capillaries and influences long-term function. Am. J. Physiol. Renal Physiol. 281, F887\u2013F899 (2001).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"3_CR24","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1016\/j.semnephrol.2015.01.010","volume":"35","author":"SK Verma","year":"2015","unstructured":"Verma, S. K. & Molitoris, B. A. Renal endothelial injury and microvascular dysfunction in acute kidney injury. Semin. Nephrol. 35, 96\u2013107 (2015).","journal-title":"Semin. Nephrol."},{"key":"3_CR25","doi-asserted-by":"publisher","first-page":"1027","DOI":"10.1681\/ASN.2014010060","volume":"26","author":"H Dimke","year":"2015","unstructured":"Dimke, H. et al. Tubulovascular cross-talk by vascular endothelial growth factor a maintains peritubular microvasculature in kidney. J. Am. Soc. Nephrol. 26, 1027\u20131038 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR26","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1093\/ckj\/sft135","volume":"7","author":"N Lameire","year":"2014","unstructured":"Lameire, N. Nephrotoxicity of recent anti-cancer agents. Clin. Kidney J. 7, 11\u201322 (2014).","journal-title":"Clin. Kidney J."},{"key":"3_CR27","doi-asserted-by":"publisher","first-page":"616","DOI":"10.1182\/blood-2014-11-611335","volume":"125","author":"ZL Al-Nouri","year":"2015","unstructured":"Al-Nouri, Z. L., Reese, J. A., Terrell, D. R., Vesely, S. K. & George, J. N. Drug-induced thrombotic microangiopathy: a systematic review of published reports. Blood 125, 616\u2013618 (2015).","journal-title":"Blood"},{"key":"3_CR28","doi-asserted-by":"publisher","first-page":"F227","DOI":"10.1152\/ajprenal.00113.2016","volume":"311","author":"D Breljak","year":"2016","unstructured":"Breljak, D. et al. Distribution of organic anion transporters NaDC3 and OAT1-3 along the human nephron. Am. J. Physiol. Renal Physiol. 311, F227\u2013F238 (2016).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"3_CR29","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1681\/ASN.V134866","volume":"13","author":"H Motohashi","year":"2002","unstructured":"Motohashi, H. et al. Gene expression levels and immunolocalization of organic ion transporters in the human kidney. J. Am. Soc. Nephrol. 13, 866\u2013874 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR30","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1124\/mol.114.091777","volume":"86","author":"L Ingraham","year":"2014","unstructured":"Ingraham, L. et al. A plasma concentration of \u03b1-ketoglutarate influences the kinetic interaction of ligands with organic anion transporter 1. Mol. Pharmacol. 86, 86\u201395 (2014).","journal-title":"Mol. Pharmacol."},{"key":"3_CR31","doi-asserted-by":"publisher","first-page":"29413","DOI":"10.1074\/jbc.M004645200","volume":"275","author":"T Budiman","year":"2000","unstructured":"Budiman, T., Bamberg, E., Koepsell, H. & Nagel, G. Mechanism of electrogenic cation transport by the cloned organic cation transporter 2 from rat. J. Biol. Chem. 275, 29413\u201329420 (2000).","journal-title":"J. Biol. Chem."},{"key":"3_CR32","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1124\/mol.56.3.570","volume":"56","author":"T Cihlar","year":"1999","unstructured":"Cihlar, T. et al. The antiviral nucleotide analogs cidofovir and adefovir are novel substrates for human and rat renal organic anion transporter 1. Mol. Pharmacol. 56, 570\u2013580 (1999).","journal-title":"Mol. Pharmacol."},{"key":"3_CR33","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1681\/ASN.V113383","volume":"11","author":"ES Ho","year":"2000","unstructured":"Ho, E. S., Lin, D. C., Mendel, D. B. & Cihlar, T. Cytotoxicity of antiviral nucleotides adefovir and cidofovir is induced by the expression of human renal organic anion transporter 1. J. Am. Soc. Nephrol. 11, 383\u2013393 (2000).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR34","doi-asserted-by":"publisher","first-page":"465","DOI":"10.1208\/s12248-016-9871-8","volume":"18","author":"TTG Nieskens","year":"2016","unstructured":"Nieskens, T. T. G. et al. A human renal proximal tubule cell line with stable organic anion transporter 1 and 3 expression predictive for antiviral-induced toxicity. AAPS J. 18, 465\u2013475 (2016).","journal-title":"AAPS J."},{"key":"3_CR35","doi-asserted-by":"publisher","first-page":"2055","DOI":"10.3390\/toxins2082055","volume":"2","author":"Y Hagos","year":"2010","unstructured":"Hagos, Y. & Wolff, N. A. Assessment of the role of renal organic anion transporters in drug-induced nephrotoxicity. Toxins 2, 2055\u20132082 (2010).","journal-title":"Toxins"},{"key":"3_CR36","doi-asserted-by":"publisher","first-page":"159","DOI":"10.1517\/17425255.2011.547474","volume":"7","author":"G Ciarimboli","year":"2011","unstructured":"Ciarimboli, G. Role of organic cation transporters in drug-induced toxicity. Expert Opin. Drug Metab. Toxicol. 7, 159\u2013174 (2011).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"3_CR37","doi-asserted-by":"publisher","first-page":"F505","DOI":"10.1152\/ajprenal.90545.2008","volume":"296","author":"N Pabla","year":"2009","unstructured":"Pabla, N., Murphy, R. F., Liu, K. & Dong, Z. The copper transporter Ctr1 contributes to cisplatin uptake by renal tubular cells during cisplatin nephrotoxicity. Am. J. Physiol. Renal Physiol. 296, F505\u2013F511 (2009).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"3_CR38","doi-asserted-by":"publisher","first-page":"1783","DOI":"10.1681\/ASN.2016060606","volume":"28","author":"Y Hori","year":"2017","unstructured":"Hori, Y. et al. Megalin blockade with cilastatin suppresses drug-induced nephrotoxicity. J. Am. Soc. Nephrol. 28, 1783\u20131791 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR39","doi-asserted-by":"publisher","first-page":"331","DOI":"10.1016\/j.bcp.2014.05.018","volume":"90","author":"J Nagai","year":"2014","unstructured":"Nagai, J. & Takano, M. Entry of aminoglycosides into renal tubular epithelial cells via endocytosis-dependent and endocytosis-independent pathways. Biochem. Pharmacol. 90, 331\u2013337 (2014).","journal-title":"Biochem. Pharmacol."},{"key":"3_CR40","unstructured":"[No authors listed.] Genitourinary Development Molecular Anatomy Project. GUDMAP http:\/\/www.gudmap.org\/ (2017)."},{"key":"3_CR41","doi-asserted-by":"publisher","first-page":"2845","DOI":"10.1242\/dev.063594","volume":"138","author":"SD Harding","year":"2011","unstructured":"Harding, S. D. et al. The GUDMAP database \u2014 an online resource for genitourinary research. Development 138, 2845\u20132853 (2011).","journal-title":"Development"},{"key":"3_CR42","doi-asserted-by":"publisher","first-page":"601","DOI":"10.1007\/s00424-012-1163-2","volume":"464","author":"SE Jenkinson","year":"2012","unstructured":"Jenkinson, S. E. et al. The limitations of renal epithelial cell line HK-2 as a model of drug transporter expression and function in the proximal tubule. Pfl\u00fcg. Arch. 464, 601\u2013611 (2012).","journal-title":"Pfl\u00fcg. Arch."},{"key":"3_CR43","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1681\/ASN.V133595","volume":"13","author":"RA Aubel van","year":"2002","unstructured":"van Aubel, R. A., Smeets, P. H., Peters, J. G., Bindels, R. J. & Russel, F. G. The MRP4\/ABCC4 gene encodes a novel apical organic anion transporter in human kidney proximal tubules: putative efflux pump for urinary cAMP and cGMP. J. Am. Soc. Nephrol. 13, 595\u2013603 (2002).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR44","doi-asserted-by":"publisher","first-page":"220","DOI":"10.1038\/sj.ki.5002645","volume":"73","author":"M Huls","year":"2008","unstructured":"Huls, M. et al. The breast cancer resistance protein transporter ABCG2 is expressed in the human kidney proximal tubule apical membrane. Kidney Int. 73, 220\u2013225 (2008).","journal-title":"Kidney Int."},{"key":"3_CR45","doi-asserted-by":"publisher","first-page":"661","DOI":"10.1016\/j.mam.2012.11.004","volume":"34","author":"H Motohashi","year":"2013","unstructured":"Motohashi, H. & Inui, K. Multidrug and toxin extrusion family SLC47: Physiological, pharmacokinetic and toxicokinetic importance of MATE1 and MATE2-K. Mol. Aspects Med. 34, 661\u2013668 (2013).","journal-title":"Mol. Aspects Med."},{"key":"3_CR46","doi-asserted-by":"publisher","first-page":"475","DOI":"10.1093\/toxsci\/kfu141","volume":"141","author":"X Wen","year":"2014","unstructured":"Wen, X. et al. MDR1 transporter protects against paraquat-induced toxicity in human and mouse proximal tubule cells. Toxicol. Sci. 141, 475\u2013483 (2014).","journal-title":"Toxicol. Sci."},{"key":"3_CR47","doi-asserted-by":"publisher","first-page":"477","DOI":"10.1016\/j.bcp.2007.03.004","volume":"74","author":"S Yokoo","year":"2007","unstructured":"Yokoo, S. et al. Differential contribution of organic cation transporters, OCT2 and MATE1, in platinum agent-induced nephrotoxicity. Biochem. Pharmacol. 74, 477\u2013487 (2007).","journal-title":"Biochem. Pharmacol."},{"key":"3_CR48","doi-asserted-by":"publisher","first-page":"711","DOI":"10.1038\/nrneph.2016.159","volume":"12","author":"K Hahn","year":"2016","unstructured":"Hahn, K., Ejaz, A. A., Kanbay, M., Lanaspa, M. A. & Johnson, R. J. Acute kidney injury from SGLT2 inhibitors: potential mechanisms. Nat. Rev. Nephrol. 12, 711\u2013712 (2016).","journal-title":"Nat. Rev. Nephrol."},{"key":"3_CR49","doi-asserted-by":"publisher","first-page":"1479","DOI":"10.2337\/dc17-1011","volume":"40","author":"GN Nadkarni","year":"2017","unstructured":"Nadkarni, G. N. et al. Acute kidney injury in patients on SGLT2 inhibitors: a propensity-matched analysis. Diabetes Care 40, 1479\u20131485 (2017).","journal-title":"Diabetes Care"},{"key":"3_CR50","doi-asserted-by":"publisher","first-page":"F951","DOI":"10.1152\/ajprenal.00250.2017","volume":"313","author":"D Saly","year":"2017","unstructured":"Saly, D. & Perazella, M. A. Harnessing basic and clinic tools to evaluate SGLT2 inhibitor nephrotoxicity. Am. J. Physiol. Renal Physiol. 313, F951\u2013F954 (2017).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"3_CR51","doi-asserted-by":"publisher","first-page":"11","DOI":"10.1681\/ASN.2014030284","volume":"26","author":"ASL Yu","year":"2015","unstructured":"Yu, A. S. L. Claudins and the kidney. J. Am. Soc. Nephrol. 26, 11\u201319 (2015).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR52","doi-asserted-by":"publisher","first-page":"F886","DOI":"10.1152\/ajprenal.00114.2012","volume":"303","author":"N Markadieu","year":"2012","unstructured":"Markadieu, N. et al. A primary culture of distal convoluted tubules expressing functional thiazide-sensitive NaCl transport. Am. J. Physiol. Renal Physiol. 303, F886\u2013F892 (2012).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"3_CR53","doi-asserted-by":"publisher","first-page":"877","DOI":"10.1007\/s00424-017-2001-3","volume":"469","author":"M Fromm","year":"2017","unstructured":"Fromm, M., Piontek, J., Rosenthal, R., G\u00fcnzel, D. & Krug, S. M. Tight junctions of the proximal tubule and their channel proteins. Pfl\u00fcg. Arch. 469, 877\u2013887 (2017).","journal-title":"Pfl\u00fcg. Arch."},{"key":"3_CR54","doi-asserted-by":"publisher","first-page":"525","DOI":"10.1152\/physrev.00019.2012","volume":"93","author":"D G\u00fcnzel","year":"2013","unstructured":"G\u00fcnzel, D. & Yu, A. S. L. Claudins and the modulation of tight junction permeability. Physiol. Rev. 93, 525\u2013569 (2013).","journal-title":"Physiol. Rev."},{"key":"3_CR55","doi-asserted-by":"publisher","first-page":"520","DOI":"10.3109\/15376516.2014.948248","volume":"24","author":"J Trujillo","year":"2014","unstructured":"Trujillo, J. et al. Renal tight junction proteins are decreased in cisplatin-induced nephrotoxicity in rats. Toxicol. Mech. Methods 24, 520\u2013528 (2014).","journal-title":"Toxicol. Mech. Methods"},{"key":"3_CR56","doi-asserted-by":"publisher","first-page":"858","DOI":"10.1016\/j.bbamem.2008.07.004","volume":"1788","author":"DF Balkovetz","year":"2009","unstructured":"Balkovetz, D. F. Tight junction claudins and the kidney in sickness and in health. Biochim. Biophys. Acta 1788, 858\u2013863 (2009).","journal-title":"Biochim. Biophys. Acta"},{"key":"3_CR57","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1016\/j.tox.2007.10.022","volume":"244","author":"LH Lash","year":"2008","unstructured":"Lash, L. H., Putt, D. A. & Cai, H. Drug metabolism enzyme expression and activity in primary cultures of human proximal tubular cells. Toxicology 244, 56\u201365 (2008).","journal-title":"Toxicology"},{"key":"3_CR58","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1002\/cpt.757","volume":"102","author":"J Miners","year":"2017","unstructured":"Miners, J., Yang, X., Knights, K. & Zhang, L. The role of the kidney in drug elimination: transport, metabolism, and the impact of kidney disease on drug clearance. Clin. Pharmacol. Ther. 102, 436\u2013449 (2017).","journal-title":"Clin. Pharmacol. Ther."},{"key":"3_CR59","doi-asserted-by":"publisher","first-page":"639","DOI":"10.1124\/dmd.111.042648","volume":"40","author":"J Bolbrinker","year":"2012","unstructured":"Bolbrinker, J. et al. CYP3A5 genotype-phenotype analysis in the human kidney reveals a strong site-specific expression of CYP3A5 in the proximal tubule in carriers of the CYP3A5*1 allele. Drug Metab. Dispos. 40, 639\u2013641 (2012).","journal-title":"Drug Metab. Dispos."},{"key":"3_CR60","doi-asserted-by":"publisher","first-page":"86","DOI":"10.1124\/dmd.116.073411","volume":"45","author":"J Yu","year":"2017","unstructured":"Yu, J., Zhou, Z., Owens, K. H., Ritchie, T. K. & Ragueneau-Majlessi, I. What can be learned from recent new drug applications? A systematic review of drug interaction data for drugs approved by the US FDA in 2015. Drug Metab. Dispos. 45, 86\u2013108 (2017).","journal-title":"Drug Metab. Dispos."},{"key":"3_CR61","first-page":"57","volume":"99","author":"W Dekant","year":"2009","unstructured":"Dekant, W. The role of biotransformation and bioactivation in toxicity. EXS 99, 57\u201386 (2009).","journal-title":"EXS"},{"key":"3_CR62","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.taap.2013.05.022","volume":"272","author":"S Liu","year":"2013","unstructured":"Liu, S. et al. The role of renal proximal tubule P450 enzymes in chloroform-induced nephrotoxicity: Utility of renal specific P450 reductase knockout mouse models. Toxicol. Appl. Pharmacol. 272, 230\u2013237 (2013).","journal-title":"Toxicol. Appl. Pharmacol."},{"key":"3_CR63","doi-asserted-by":"publisher","first-page":"269","DOI":"10.14573\/altex.1311152","volume":"31","author":"L Fliedl","year":"2014","unstructured":"Fliedl, L. Controversial role of gamma-glutamyl transferase activity in cisplatin nephrotoxicity. ALTEX 31, 269\u2013278 (2014).","journal-title":"ALTEX"},{"key":"3_CR64","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1016\/S0076-6879(81)77032-0","volume":"77","author":"A Meister","year":"1981","unstructured":"Meister, A., Tate, S. S. & Griffith, O. W. Gamma-glutamyl transpeptidase. Methods Enzymol. 77, 237\u2013253 (1981).","journal-title":"Methods Enzymol."},{"key":"3_CR65","doi-asserted-by":"publisher","first-page":"123","DOI":"10.3389\/fphys.2017.00123","volume":"8","author":"SM King","year":"2017","unstructured":"King, S. M. et al. 3D proximal tubule tissues recapitulate key aspects of renal physiology to enable nephrotoxicity testing. Front. Physiol. 8, 123 (2017).","journal-title":"Front. Physiol."},{"key":"3_CR66","doi-asserted-by":"publisher","first-page":"F1365","DOI":"10.1152\/ajprenal.90405.2008","volume":"295","author":"M Wieser","year":"2008","unstructured":"Wieser, M. et al. hTERT alone immortalizes epithelial cells of renal proximal tubules without changing their functional characteristics. Am. J. Physiol. Renal Physiol. 295, F1365\u2013F1375 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"3_CR67","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/j.kint.2016.06.011","volume":"90","author":"EJ Weber","year":"2016","unstructured":"Weber, E. J. et al. Development of a microphysiological model of human kidney proximal tubule function. Kidney Int. 90, 627\u2013637 (2016).","journal-title":"Kidney Int."},{"key":"3_CR68","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/ki.2009.91","volume":"76","author":"MLA Kortenoeven","year":"2009","unstructured":"Kortenoeven, M. L. A. et al. Amiloride blocks lithium entry through the sodium channel thereby attenuating the resultant nephrogenic diabetes insipidus. Kidney Int. 76, 44\u201353 (2009).","journal-title":"Kidney Int."},{"key":"3_CR69","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1093\/ndt\/gfk029","volume":"21","author":"K Thomsen","year":"2006","unstructured":"Thomsen, K. & Shirley, D. G. A hypothesis linking sodium and lithium reabsorption in the distal nephron. Nephrol. Dial. Transplant. 21, 869\u2013880 (2006).","journal-title":"Nephrol. Dial. Transplant."},{"key":"3_CR70","doi-asserted-by":"publisher","first-page":"F39","DOI":"10.1152\/ajprenal.00383.2005","volume":"291","author":"BM Christensen","year":"2006","unstructured":"Christensen, B. M., Kim, Y.-H., Kwon, T.-H. & Nielsen, S. Lithium treatment induces a marked proliferation of primarily principal cells in rat kidney inner medullary collecting duct. Am. J. Physiol. Renal Physiol. 291, F39\u2013F48 (2006).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"3_CR71","doi-asserted-by":"publisher","first-page":"F486","DOI":"10.1152\/ajprenal.00116.2011","volume":"301","author":"KJ Ledeganck","year":"2011","unstructured":"Ledeganck, K. J. et al. Expression of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment. Am. J. Physiol. Renal Physiol. 301, F486\u2013F493 (2011).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"3_CR72","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1038\/nbt0510-436","volume":"28","author":"JV Bonventre","year":"2010","unstructured":"Bonventre, J. V., Vaidya, V. S., Schmouder, R., Feig, P. & Dieterle, F. Next-generation biomarkers for detecting kidney toxicity. Nat. Biotechnol. 28, 436\u2013440 (2010).","journal-title":"Nat. Biotechnol."},{"key":"3_CR73","doi-asserted-by":"publisher","first-page":"39739","DOI":"10.1074\/jbc.M200562200","volume":"277","author":"V Bailly","year":"2002","unstructured":"Bailly, V. et al. Shedding of kidney injury molecule-1, a putative adhesion protein involved in renal regeneration. J. Biol. Chem. 277, 39739\u201339748 (2002).","journal-title":"J. Biol. Chem."},{"key":"3_CR74","doi-asserted-by":"publisher","first-page":"552F","DOI":"10.1152\/ajprenal.00285.2002","volume":"286","author":"T Ichimura","year":"2004","unstructured":"Ichimura, T. Kidney injury molecule-1: a tissue and urinary biomarker for nephrotoxicant-induced renal injury. Am. J. Physiol. Renal Physiol. 286, 552F\u2013563 (2004).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"3_CR75","doi-asserted-by":"publisher","first-page":"1657","DOI":"10.1172\/JCI34487","volume":"118","author":"T Ichimura","year":"2008","unstructured":"Ichimura, T. et al. Kidney injury molecule-1 is a phosphatidylserine receptor that confers a phagocytic phenotype on epithelial cells. J. Clin. Invest. 118, 1657\u20131668 (2008).","journal-title":"J. Clin. Invest."},{"key":"3_CR76","doi-asserted-by":"publisher","first-page":"F517","DOI":"10.1152\/ajprenal.00291.2005","volume":"290","author":"VS Vaidya","year":"2006","unstructured":"Vaidya, V. S. Urinary kidney injury molecule-1: a sensitive quantitative biomarker for early detection of kidney tubular injury. Am. J. Physiol. Renal Physiol. 290, F517\u2013F529 (2006).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"3_CR77","doi-asserted-by":"publisher","first-page":"478","DOI":"10.1038\/nbt.1623","volume":"28","author":"VS Vaidya","year":"2010","unstructured":"Vaidya, V. S. et al. Kidney injury molecule-1 outperforms traditional biomarkers of kidney injury in preclinical biomarker qualification studies. Nat. Biotechnol. 28, 478\u2013485 (2010).","journal-title":"Nat. Biotechnol."},{"key":"3_CR78","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1111\/j.1752-8062.2008.00053.x","volume":"1","author":"VS Vaidya","year":"2008","unstructured":"Vaidya, V. S. et al. Urinary biomarkers for sensitive and specific detection of acute kidney injury in humans. Clin. Transl Sci. 1, 200\u2013208 (2008).","journal-title":"Clin. Transl Sci."},{"key":"3_CR79","doi-asserted-by":"publisher","first-page":"455","DOI":"10.1038\/nbt.1625","volume":"28","author":"F Dieterle","year":"2010","unstructured":"Dieterle, F. et al. Renal biomarker qualification submission: a dialog between the FDA-EMEA and Predictive Safety Testing Consortium. Nat. Biotechnol. 28, 455\u2013462 (2010).","journal-title":"Nat. Biotechnol."},{"key":"3_CR80","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1093\/toxsci\/kfn040","volume":"103","author":"E Rached","year":"2008","unstructured":"Rached, E. et al. Evaluation of putative biomarkers of nephrotoxicity after exposure to ochratoxin A in vivo and in vitro. Toxicol. Sci 103, 371\u2013381 (2008).","journal-title":"Toxicol. Sci"},{"key":"3_CR81","doi-asserted-by":"publisher","first-page":"235","DOI":"10.1016\/j.toxlet.2012.12.015","volume":"217","author":"S-J Sohn","year":"2013","unstructured":"Sohn, S.-J. et al. In vitro evaluation of biomarkers for cisplatin-induced nephrotoxicity using HK-2 human kidney epithelial cells. Toxicol. Lett. 217, 235\u2013242 (2013).","journal-title":"Toxicol. Lett."},{"key":"3_CR82","doi-asserted-by":"publisher","first-page":"352","DOI":"10.1039\/c3tx50042j","volume":"2","author":"Y Li","year":"2013","unstructured":"Li, Y. et al. An in vitro method for the prediction of renal proximal tubular toxicity in humans. Toxicol. Res 2, 352 (2013).","journal-title":"Toxicol. Res"},{"key":"3_CR83","doi-asserted-by":"publisher","first-page":"911","DOI":"10.1159\/000452592","volume":"41","author":"Q-H Luo","year":"2016","unstructured":"Luo, Q.-H. et al. Evaluation of KIM-1 and NGAL as early indicators for assessment of gentamycin-induced nephrotoxicity in vivo and in vitro. Kidney Blood Press. Res 41, 911\u2013918 (2016).","journal-title":"Kidney Blood Press. Res"},{"key":"3_CR84","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1146\/annurev.pharmtox.010909.105600","volume":"50","author":"R Gozzelino","year":"2010","unstructured":"Gozzelino, R., Jeney, V. & Soares, M. P. Mechanisms of cell protection by heme oxygenase-1. Annu. Rev. Pharmacol. Toxicol. 50, 323\u2013354 (2010).","journal-title":"Annu. Rev. Pharmacol. Toxicol."},{"key":"3_CR85","doi-asserted-by":"publisher","unstructured":"Lever, J. M., Boddu, R., George, J. F. & Agarwal, A. Heme oxygenase-1 in kidney health and disease. Antioxid. Redox Signal. https:\/\/doi.org\/10.1089\/ars.2016.6659 (2016).","DOI":"10.1089\/ars.2016.6659"},{"key":"3_CR86","doi-asserted-by":"publisher","first-page":"1048","DOI":"10.1681\/ASN.2011121147","volume":"23","author":"RA Zager","year":"2012","unstructured":"Zager, R. A., Johnson, A. C. M. & Becker, K. Plasma and urinary heme oxygenase-1 in AKI. J. Am. Soc. Nephrol. 23, 1048\u20131057 (2012).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR87","doi-asserted-by":"publisher","first-page":"1015","DOI":"10.1681\/ASN.2015010060","volume":"27","author":"M Adler","year":"2016","unstructured":"Adler, M. et al. A quantitative approach to screen for nephrotoxic compounds in vitro. J. Am. Soc. Nephrol. 27, 1015\u20131028 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR88","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.jaci.2010.11.050","volume":"127","author":"M Akdis","year":"2011","unstructured":"Akdis, M. et al. Interleukins, from 1 to 37, and interferon-\u03b3: receptors, functions, and roles in diseases. J. Allergy Clin. Immunol. 127, 701\u2013721.e70 (2011).","journal-title":"J. Allergy Clin. Immunol."},{"key":"3_CR89","doi-asserted-by":"publisher","first-page":"1525","DOI":"10.1007\/s00467-012-2156-2","volume":"27","author":"D Tramma","year":"2012","unstructured":"Tramma, D., Hatzistylianou, M., Gerasimou, G. & Lafazanis, V. Interleukin-6 and interleukin-8 levels in the urine of children with renal scarring. Pediatr. Nephrol. 27, 1525\u20131530 (2012).","journal-title":"Pediatr. Nephrol."},{"key":"3_CR90","doi-asserted-by":"publisher","first-page":"547","DOI":"10.1681\/ASN.2007040469","volume":"19","author":"DN Grigoryev","year":"2008","unstructured":"Grigoryev, D. N. et al. The local and systemic inflammatory transcriptome after acute kidney injury. J. Am. Soc. Nephrol. 19, 547\u2013558 (2008).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR91","doi-asserted-by":"publisher","first-page":"783","DOI":"10.1097\/01.tp.0000198736.69527.32","volume":"81","author":"M Araki","year":"2006","unstructured":"Araki, M. et al. Expression of IL-8 during reperfusion of renal allografts is dependent on ischemic time. Transplantation 81, 783\u2013788 (2006).","journal-title":"Transplantation"},{"key":"3_CR92","doi-asserted-by":"publisher","first-page":"405","DOI":"10.3389\/fimmu.2017.00405","volume":"8","author":"H Su","year":"2017","unstructured":"Su, H., Lei, C.-T. & Zhang, C. Interleukin-6 signaling pathway and its role in kidney disease: an update. Front. Immunol. 8, 405 (2017).","journal-title":"Front. Immunol."},{"key":"3_CR93","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-07582-1","volume":"7","author":"M Mihajlovic","year":"2017","unstructured":"Mihajlovic, M. et al. Allostimulatory capacity of conditionally immortalized proximal tubule cell lines for bioartificial kidney application. Sci. Rep. 7, 7103 (2017).","journal-title":"Sci. Rep."},{"key":"3_CR94","doi-asserted-by":"publisher","first-page":"17","DOI":"10.1006\/geno.1997.4896","volume":"45","author":"JB Cowland","year":"1997","unstructured":"Cowland, J. B. & Borregaard, N. Molecular characterization and pattern of tissue expression of the gene for neutrophil gelatinase-associated lipocalin from humans. Genomics 45, 17\u201323 (1997).","journal-title":"Genomics"},{"key":"3_CR95","doi-asserted-by":"publisher","first-page":"1301","DOI":"10.1093\/ndt\/gft510","volume":"29","author":"JR Charlton","year":"2014","unstructured":"Charlton, J. R., Portilla, D. & Okusa, M. D. A basic science view of acute kidney injury biomarkers. Nephrol. Dial. Transplant. 29, 1301\u20131311 (2014).","journal-title":"Nephrol. Dial. Transplant."},{"key":"3_CR96","doi-asserted-by":"publisher","first-page":"216","DOI":"10.1038\/nm.2290","volume":"17","author":"N Paragas","year":"2011","unstructured":"Paragas, N. et al. The Ngal reporter mouse detects the response of the kidney to injury in real time. Nat. Med. 17, 216\u2013222 (2011).","journal-title":"Nat. Med."},{"key":"3_CR97","doi-asserted-by":"publisher","first-page":"211","DOI":"10.2215\/CJN.04240609","volume":"5","author":"DR McIlroy","year":"2010","unstructured":"McIlroy, D. R., Wagener, G. & Lee, H. T. Neutrophil gelatinase-associated lipocalin and acute kidney injury after cardiac surgery: the effect of baseline renal function on diagnostic performance. Clin. J. Am. Soc. Nephrol. 5, 211\u2013219 (2010).","journal-title":"Clin. J. Am. Soc. Nephrol."},{"key":"3_CR98","doi-asserted-by":"publisher","first-page":"304","DOI":"10.1159\/000364937","volume":"37","author":"J M\u00e5rtensson","year":"2014","unstructured":"M\u00e5rtensson, J. & Bellomo, R. The rise and fall of NGAL in acute kidney injury. Blood Purif. 37, 304\u2013310 (2014).","journal-title":"Blood Purif."},{"key":"3_CR99","doi-asserted-by":"publisher","first-page":"1012","DOI":"10.1053\/j.ajkd.2009.07.020","volume":"54","author":"M Haase","year":"2009","unstructured":"Haase, M. et al. Accuracy of neutrophil gelatinase-associated lipocalin (NGAL) in diagnosis and prognosis in acute kidney injury: a systematic review and meta-analysis. Am. J. Kidney Dis. 54, 1012\u20131024 (2009).","journal-title":"Am. J. Kidney Dis."},{"key":"3_CR100","doi-asserted-by":"publisher","first-page":"1082","DOI":"10.1208\/s12248-016-9959-1","volume":"18","author":"D Scotcher","year":"2016","unstructured":"Scotcher, D., Jones, C., Posada, M., Galetin, A. & Rostami-Hodjegan, A. Key to opening kidney for in vitro-in vivo extrapolation entrance in health and disease: Part II: mechanistic models and in vitro-in vivo extrapolation. AAPS J. 18, 1082\u20131094 (2016).","journal-title":"AAPS J."},{"key":"3_CR101","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1124\/dmd.107.014902","volume":"35","author":"C Hilgendorf","year":"2007","unstructured":"Hilgendorf, C. et al. Expression of thirty-six drug transporter genes in human intestine, liver, kidney, and organotypic cell lines. Drug Metab. Dispos. 35, 1333\u20131340 (2007).","journal-title":"Drug Metab. Dispos."},{"key":"3_CR102","doi-asserted-by":"publisher","first-page":"237","DOI":"10.1517\/17425255.2013.741589","volume":"9","author":"X Chu","year":"2013","unstructured":"Chu, X., Bleasby, K. & Evers, R. Species differences in drug transporters and implications for translating preclinical findings to humans. Expert Opin. Drug Metab. Toxicol. 9, 237\u2013252 (2013).","journal-title":"Expert Opin. Drug Metab. Toxicol."},{"key":"3_CR103","doi-asserted-by":"publisher","first-page":"1817","DOI":"10.1111\/j.1476-5381.2011.01394.x","volume":"164","author":"A Yonezawa","year":"2011","unstructured":"Yonezawa, A. & Inui, K. Importance of the multidrug and toxin extrusion MATE\/SLC47A family to pharmacokinetics, pharmacodynamics\/toxicodynamics and pharmacogenomics. Br. J. Pharmacol. 164, 1817\u20131825 (2011).","journal-title":"Br. J. Pharmacol."},{"key":"3_CR104","doi-asserted-by":"publisher","first-page":"F165","DOI":"10.1152\/ajprenal.90257.2008","volume":"295","author":"M Aoki","year":"2008","unstructured":"Aoki, M. et al. Kidney-specific expression of human organic cation transporter 2 (OCT2\/SLC22A2) is regulated by DNA methylation. Am. J. Physiol. Renal Physiol. 295, F165\u2013F170 (2008).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"3_CR105","doi-asserted-by":"publisher","first-page":"181","DOI":"10.1016\/j.bbrc.2004.11.012","volume":"326","author":"Y Tanaka","year":"2004","unstructured":"Tanaka, Y., Slitt, A. L., Leazer, T. M., Maher, J. M. & Klaassen, C. D. Tissue distribution and hormonal regulation of the breast cancer resistance protein (Bcrp\/Abcg2) in rats and mice. Biochem. Biophys. Res. Commun. 326, 181\u2013187 (2004).","journal-title":"Biochem. Biophys. Res. Commun."},{"key":"3_CR106","doi-asserted-by":"publisher","first-page":"143","DOI":"10.2165\/00003088-200948030-00001","volume":"48","author":"OP Soldin","year":"2009","unstructured":"Soldin, O. P. & Mattison, D. R. Sex differences in pharmacokinetics and pharmacodynamics. Clin. Pharmacokinet. 48, 143\u2013157 (2009).","journal-title":"Clin. Pharmacokinet."},{"key":"3_CR107","doi-asserted-by":"publisher","first-page":"4","DOI":"10.1186\/s13293-015-0020-3","volume":"6","author":"S Joseph","year":"2015","unstructured":"Joseph, S. et al. Expression of drug transporters in human kidney: impact of sex, age, and ethnicity. Biol. Sex Differ. 6, 4 (2015).","journal-title":"Biol. Sex Differ."},{"key":"3_CR108","doi-asserted-by":"publisher","first-page":"3504","DOI":"10.1681\/ASN.2017030295","volume":"28","author":"LC Veiras","year":"2017","unstructured":"Veiras, L. C. et al. Sexual dimorphic pattern of renal transporters and electrolyte homeostasis. J. Am. Soc. Nephrol. 28, 3504\u20133517 (2017).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR109","unstructured":"[No authors listed.] Validating human stem cell cardiomyocyte technology for better predictive assessment of drug-induced cardiac toxicity. U.S. Food & Drug Administration https:\/\/www.fda.gov\/ScienceResearch\/SpecialTopics\/RegulatoryScience\/ucm507998.htm (2016)."},{"key":"3_CR110","doi-asserted-by":"publisher","first-page":"156","DOI":"10.1016\/j.tibtech.2015.11.001","volume":"34","author":"MJ Wilmer","year":"2016","unstructured":"Wilmer, M. J. et al. Kidney-on-a-chip technology for drug-induced nephrotoxicity screening. Trends Biotechnol. 34, 156\u2013170 (2016).","journal-title":"Trends Biotechnol."},{"key":"3_CR111","doi-asserted-by":"publisher","first-page":"48","DOI":"10.1038\/ki.1994.6","volume":"45","author":"MJ Ryan","year":"1994","unstructured":"Ryan, M. J. et al. HK-2: An immortalized proximal tubule epithelial cell line from normal adult human kidney. Kidney Int. 45, 48\u201357 (1994).","journal-title":"Kidney Int."},{"key":"3_CR112","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1007\/s00441-009-0882-y","volume":"339","author":"MJ Wilmer","year":"2010","unstructured":"Wilmer, M. J. et al. Novel conditionally immortalized human proximal tubule cell line expressing functional influx and efflux transporters. Cell Tissue Res. 339, 449\u2013457 (2010).","journal-title":"Cell Tissue Res."},{"key":"3_CR113","doi-asserted-by":"publisher","first-page":"95","DOI":"10.1016\/j.tiv.2014.12.003","volume":"30","author":"L Aschauer","year":"2015","unstructured":"Aschauer, L., Carta, G., Vogelsang, N., Schlatter, E. & Jennings, P. Expression of xenobiotic transporters in the human renal proximal tubule cell line RPTEC\/TERT1. Toxicol. In Vitro 30, 95\u2013105 (2015).","journal-title":"Toxicol. In Vitro"},{"key":"3_CR114","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1007\/s00424-013-1307-z","volume":"465","author":"CMS Schophuizen","year":"2013","unstructured":"Schophuizen, C. M. S. et al. Cationic uremic toxins affect human renal proximal tubule cell functioning through interaction with the organic cation transporter. Pfl\u00fcg. Arch. 465, 1701\u20131714 (2013).","journal-title":"Pfl\u00fcg. Arch."},{"key":"3_CR115","first-page":"2013","volume":"142\u2013150","author":"HAM Mutsaers","year":"1832","unstructured":"Mutsaers, H. A. M. et al. Uremic toxins inhibit renal metabolic capacity through interference with glucuronidation and mitochondrial respiration. Biochim. Biophys. Acta 1832, 142\u2013150 (2013).","journal-title":"Biochim. Biophys. Acta"},{"key":"3_CR116","doi-asserted-by":"publisher","DOI":"10.1038\/srep26715","volume":"6","author":"J Jansen","year":"2016","unstructured":"Jansen, J. et al. Bioengineered kidney tubules efficiently excrete uremic toxins. Sci. Rep. 6, 26715 (2016).","journal-title":"Sci. Rep."},{"key":"3_CR117","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0035618","volume":"7","author":"AE Ivliev","year":"2012","unstructured":"Ivliev, A. E., \u2019t Hoen, P. A. C., Roon-Mom, W. M. C., van, Peters, D. J. M. & Sergeeva, M. G. Exploring the transcriptome of ciliated cells using in silico dissection of human tissues. PLoS ONE 7, e35618 (2012).","journal-title":"PLoS ONE"},{"key":"3_CR118","doi-asserted-by":"publisher","first-page":"20140367","DOI":"10.1098\/rstb.2014.0367","volume":"370","author":"M Ohnuki","year":"2015","unstructured":"Ohnuki, M. & Takahashi, K. Present and future challenges of induced pluripotent stem cells. Phil. Trans. R. Soc. B Biol Sci. 370, 20140367 (2015).","journal-title":"Phil. Trans. R. Soc. B Biol Sci."},{"key":"3_CR119","doi-asserted-by":"publisher","first-page":"1211","DOI":"10.1681\/ASN.2013080831","volume":"25","author":"AQ Lam","year":"2014","unstructured":"Lam, A. Q. et al. Rapid and efficient differentiation of human pluripotent stem cells into intermediate mesoderm that forms tubules expressing kidney proximal tubular markers. J. Am. Soc. Nephrol. 25, 1211\u20131225 (2014).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR120","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms2378","volume":"4","author":"S-I Mae","year":"2013","unstructured":"Mae, S.-I. et al. Monitoring and robust induction of nephrogenic intermediate mesoderm from human pluripotent stem cells. Nat. Commun. 4, 1367 (2013).","journal-title":"Nat. Commun."},{"key":"3_CR121","doi-asserted-by":"publisher","first-page":"2693","DOI":"10.1038\/nprot.2014.182","volume":"9","author":"Y Xia","year":"2014","unstructured":"Xia, Y. et al. The generation of kidney organoids by differentiation of human pluripotent cells to ureteric bud progenitor-like cells. Nat. Protoc. 9, 2693\u20132704 (2014).","journal-title":"Nat. Protoc."},{"key":"3_CR122","doi-asserted-by":"publisher","first-page":"53","DOI":"10.1016\/j.stem.2013.11.010","volume":"14","author":"A Taguchi","year":"2014","unstructured":"Taguchi, A. et al. Redefining the in vivo origin of metanephric nephron progenitors enables generation of complex kidney structures from pluripotent stem cells. Cell Stem Cell 14, 53\u201367 (2014).","journal-title":"Cell Stem Cell"},{"key":"3_CR123","doi-asserted-by":"publisher","DOI":"10.1038\/ncomms9715","volume":"6","author":"BS Freedman","year":"2015","unstructured":"Freedman, B. S. et al. Modelling kidney disease with CRISPR-mutant kidney organoids derived from human pluripotent epiblast spheroids. Nat. Commun. 6, 8715 (2015).","journal-title":"Nat. Commun."},{"key":"3_CR124","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1038\/nature15695","volume":"526","author":"M Takasato","year":"2015","unstructured":"Takasato, M. et al. Kidney organoids from human iPS cells contain multiple lineages and model human nephrogenesis. Nature 526, 564\u2013568 (2015).","journal-title":"Nature"},{"key":"3_CR125","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1038\/nbt.3392","volume":"33","author":"R Morizane","year":"2015","unstructured":"Morizane, R. et al. Nephron organoids derived from human pluripotent stem cells model kidney development and injury. Nat. Biotechnol. 33, 1193\u20131200 (2015).","journal-title":"Nat. Biotechnol."},{"key":"3_CR126","doi-asserted-by":"publisher","DOI":"10.1038\/srep12337","volume":"5","author":"K Kandasamy","year":"2015","unstructured":"Kandasamy, K. et al. Prediction of drug-induced nephrotoxicity and injury mechanisms with human induced pluripotent stem cell-derived cells and machine learning methods. Sci. Rep. 5, 12337 (2015).","journal-title":"Sci. Rep."},{"key":"3_CR127","doi-asserted-by":"publisher","DOI":"10.1038\/srep08826","volume":"5","author":"B Imberti","year":"2015","unstructured":"Imberti, B. et al. Renal progenitors derived from human iPSCs engraft and restore function in a mouse model of acute kidney injury. Sci. Rep. 5, 8826 (2015).","journal-title":"Sci. Rep."},{"key":"3_CR128","doi-asserted-by":"publisher","first-page":"0069","DOI":"10.1038\/s41551-017-0069","volume":"1","author":"S Musah","year":"2017","unstructured":"Musah, S. et al. Mature induced-pluripotent-stem-cell-derived human podocytes reconstitute kidney glomerular-capillary-wall function on a chip. Nat. Biomed. Eng. 1, 0069 (2017).","journal-title":"Nat. Biomed. Eng."},{"key":"3_CR129","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0046453","volume":"7","author":"B Song","year":"2012","unstructured":"Song, B. et al. The directed differentiation of human iPS cells into kidney podocytes. PLoS ONE 7, e46453 (2012).","journal-title":"PLoS ONE"},{"key":"3_CR130","doi-asserted-by":"publisher","first-page":"1269","DOI":"10.1038\/ncb3437","volume":"18","author":"MM Kaminski","year":"2016","unstructured":"Kaminski, M. M. et al. Direct reprogramming of fibroblasts into renal tubular epithelial cells by defined transcription factors. Nat. Cell Biol. 18, 1269\u20131280 (2016).","journal-title":"Nat. Cell Biol."},{"key":"3_CR131","doi-asserted-by":"publisher","first-page":"119","DOI":"10.1016\/j.stem.2015.01.013","volume":"16","author":"J Xu","year":"2015","unstructured":"Xu, J., Du, Y. & Deng, H. Direct lineage reprogramming: strategies, mechanisms, and applications. Cell Stem Cell 16, 119\u2013134 (2015).","journal-title":"Cell Stem Cell"},{"key":"3_CR132","doi-asserted-by":"publisher","first-page":"118","DOI":"10.1038\/ncb2894","volume":"16","author":"M Takasato","year":"2014","unstructured":"Takasato, M. et al. Directing human embryonic stem cell differentiation towards a renal lineage generates a self-organizing kidney. Nat. Cell Biol. 16, 118\u2013126 (2014).","journal-title":"Nat. Cell Biol."},{"key":"3_CR133","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1039\/c3ib40049b","volume":"5","author":"K-J Jang","year":"2013","unstructured":"Jang, K.-J. et al. Human kidney proximal tubule-on-a-chip for drug transport and nephrotoxicity assessment. Integr. Biol. 5, 1119 (2013).","journal-title":"Integr. Biol."},{"key":"3_CR134","doi-asserted-by":"publisher","DOI":"10.1038\/srep34845","volume":"6","author":"KA Homan","year":"2016","unstructured":"Homan, K. A. et al. Bioprinting of 3D convoluted renal proximal tubules on perfusable chips. Sci. Rep. 6, 34845 (2016).","journal-title":"Sci. Rep."},{"key":"3_CR135","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1177\/1535370214539228","volume":"239","author":"A Tourovskaia","year":"2014","unstructured":"Tourovskaia, A., Fauver, M., Kramer, G., Simonson, S. & Neumann, T. Tissue-engineered microenvironment systems for modeling human vasculature. Exp. Biol. Med. 239, 1264\u20131271 (2014).","journal-title":"Exp. Biol. Med."},{"key":"3_CR136","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1038\/sj.bjp.0703541","volume":"131","author":"R Masereeuw","year":"2000","unstructured":"Masereeuw, R. et al. Probenecid interferes with renal oxidative metabolism: a potential pitfall in its use as an inhibitor of drug transport. Br. J. Pharmacol. 131, 57\u201362 (2000).","journal-title":"Br. J. Pharmacol."},{"key":"3_CR137","doi-asserted-by":"publisher","first-page":"408","DOI":"10.1172\/JCI58753","volume":"122","author":"M Tsai","year":"2012","unstructured":"Tsai, M. et al. In vitro modeling of the microvascular occlusion and thrombosis that occur in hematologic diseases using microfluidic technology. J. Clin. Invest. 122, 408\u2013418 (2012).","journal-title":"J. Clin. Invest."},{"key":"3_CR138","doi-asserted-by":"publisher","first-page":"2370","DOI":"10.1681\/ASN.2015070747","volume":"27","author":"G Ligresti","year":"2016","unstructured":"Ligresti, G. et al. A novel three-dimensional human peritubular microvascular system. J. Am. Soc. Nephrol. 27, 2370\u20132381 (2016).","journal-title":"J. Am. Soc. Nephrol."},{"key":"3_CR139","doi-asserted-by":"publisher","first-page":"S17","DOI":"10.1186\/scrt378","volume":"4","author":"EJ Kelly","year":"2013","unstructured":"Kelly, E. J. et al. Innovations in preclinical biology: ex vivo engineering of a human kidney tissue microperfusion system. Stem Cell Res. Ther. 4, S17 (2013).","journal-title":"Stem Cell Res. Ther."},{"key":"3_CR140","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1039\/C6LC01422D","volume":"17","author":"DTT Phan","year":"2017","unstructured":"Phan, D. T. T. et al. A vascularized and perfused organ-on-a-chip platform for large-scale drug screening applications. Lab Chip 17, 511\u2013520 (2017).","journal-title":"Lab Chip"},{"key":"3_CR141","doi-asserted-by":"publisher","DOI":"10.1038\/s41598-017-14716-y","volume":"7","author":"V Duinen van","year":"2017","unstructured":"van Duinen, V. et al. 96 perfusable blood vessels to study vascular permeability in vitro. Sci. Rep. 7, 18071 (2017).","journal-title":"Sci. Rep."},{"key":"3_CR142","doi-asserted-by":"publisher","DOI":"10.1038\/srep42296","volume":"7","author":"L Vernetti","year":"2017","unstructured":"Vernetti, L. et al. Functional coupling of human microphysiology systems: intestine, liver, kidney proximal tubule, blood-brain barrier and skeletal muscle. Sci. Rep. 7, 42296 (2017).","journal-title":"Sci. Rep."},{"key":"3_CR143","doi-asserted-by":"publisher","first-page":"95978","DOI":"10.1172\/jci.insight.95978","volume":"2","author":"S-Y Chang","year":"2017","unstructured":"Chang, S.-Y. et al. Human liver-kidney model elucidates the mechanisms of aristolochic acid nephrotoxicity. JCI Insight 2, 95978 (2017).","journal-title":"JCI Insight"},{"key":"3_CR144","doi-asserted-by":"publisher","DOI":"10.1038\/srep16702","volume":"5","author":"J Jansen","year":"2015","unstructured":"Jansen, J. et al. Human proximal tubule epithelial cells cultured on hollow fibers: living membranes that actively transport organic cations. Sci. Rep. 5, 16702 (2015).","journal-title":"Sci. Rep."},{"key":"3_CR145","doi-asserted-by":"publisher","first-page":"2531","DOI":"10.3390\/ijms18122531","volume":"18","author":"M Mihajlovic","year":"2017","unstructured":"Mihajlovic, M. et al. Role of vitamin D in maintaining renal epithelial barrier function in uremic conditions. Int. J. Mol. Sci. 18, 2531 (2017).","journal-title":"Int. J. Mol. Sci."},{"key":"3_CR146","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0158674","volume":"11","author":"DG Nguyen","year":"2016","unstructured":"Nguyen, D. G. et al. Bioprinted 3D primary liver tissues allow assessment of organ-level response to clinical drug induced toxicity in vitro. PLoS ONE 11, e0158674 (2016).","journal-title":"PLoS ONE"},{"key":"3_CR147","doi-asserted-by":"publisher","first-page":"1998","DOI":"10.1021\/acs.chemrestox.6b00248","volume":"29","author":"M Persson","year":"2016","unstructured":"Persson, M. & Hornberg, J. J. Advances in predictive toxicology for discovery safety through high content screening. Chem. Res. Toxicol. 29, 1998\u20132007 (2016).","journal-title":"Chem. Res. Toxicol."},{"key":"3_CR148","doi-asserted-by":"publisher","first-page":"2793","DOI":"10.1007\/s00204-015-1638-y","volume":"90","author":"R Su","year":"2016","unstructured":"Su, R., Xiong, S., Zink, D. & Loo, L.-H. High-throughput imaging-based nephrotoxicity prediction for xenobiotics with diverse chemical structures. Arch. Toxicol. 90, 2793\u20132808 (2016).","journal-title":"Arch. Toxicol."},{"key":"3_CR149","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1016\/j.fct.2016.03.017","volume":"92","author":"R Abdullah","year":"2016","unstructured":"Abdullah, R., Alhusainy, W., Woutersen, J., Rietjens, I. M. C. M. & Punt, A. Predicting points of departure for risk assessment based on in vitro cytotoxicity data and physiologically based kinetic (PBK) modeling: The case of kidney toxicity induced by aristolochic acid I. Food Chem. Toxicol. 92, 104\u2013116 (2016).","journal-title":"Food Chem. Toxicol."},{"key":"3_CR150","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1080\/03602530902843483","volume":"41","author":"S-F Zhou","year":"2009","unstructured":"Zhou, S.-F., Liu, J.-P. & Chowbay, B. Polymorphism of human cytochrome P450 enzymes and its clinical impact. Drug Metab. Rev. 41, 89\u2013295 (2009).","journal-title":"Drug Metab. Rev."},{"key":"3_CR151","doi-asserted-by":"publisher","first-page":"556","DOI":"10.1124\/dmd.117.075242","volume":"45","author":"D Scotcher","year":"2017","unstructured":"Scotcher, D. et al. Microsomal and cytosolic scaling factors in dog and human kidney cortex and application for in vitro-in vivo extrapolation of renal metabolic clearance. Drug Metab. Dispos. 45, 556\u2013568 (2017).","journal-title":"Drug Metab. Dispos."},{"key":"3_CR152","doi-asserted-by":"publisher","first-page":"330","DOI":"10.1002\/jat.3191","volume":"36","author":"E Leclerc","year":"2016","unstructured":"Leclerc, E., Hamon, J. & Bois, F. Y. Investigation of ifosfamide and chloroacetaldehyde renal toxicity through integration of in vitro liver\u2013kidney microfluidic data and pharmacokinetic-system biology models. J. Appl. Toxicol. 36, 330\u2013339 (2016).","journal-title":"J. Appl. Toxicol."},{"key":"3_CR153","doi-asserted-by":"publisher","first-page":"2490","DOI":"10.3390\/toxins2112490","volume":"2","author":"RP Miller","year":"2010","unstructured":"Miller, R. P., Tadagavadi, R. K., Ramesh, G. & Reeves, W. B. Mechanisms of cisplatin nephrotoxicity. Toxins 2, 2490\u20132518 (2010).","journal-title":"Toxins"},{"key":"3_CR154","doi-asserted-by":"publisher","first-page":"1762","DOI":"10.1016\/j.bcp.2010.08.019","volume":"80","author":"T Nakamura","year":"2010","unstructured":"Nakamura, T., Yonezawa, A., Hashimoto, S., Katsura, T. & Inui, K. Disruption of multidrug and toxin extrusion MATE1 potentiates cisplatin-induced nephrotoxicity. Biochem. Pharmacol. 80, 1762\u20131767 (2010).","journal-title":"Biochem. Pharmacol."},{"key":"3_CR155","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1111\/cts.12480","volume":"10","author":"S Hu","year":"2017","unstructured":"Hu, S. et al. Identification of OAT1\/OAT3 as contributors to cisplatin toxicity. Clin. Transl Sci. 10, 412\u2013420 (2017).","journal-title":"Clin. Transl Sci."},{"key":"3_CR156","doi-asserted-by":"publisher","first-page":"1715","DOI":"10.1016\/j.ajpath.2014.02.008","volume":"184","author":"R Sonneveld","year":"2014","unstructured":"Sonneveld, R. et al. Glucose specifically regulates TRPC6 expression in the podocyte in an AngII-dependent manner. Am. J. Pathol. 184, 1715\u20131726 (2014).","journal-title":"Am. J. Pathol."},{"key":"3_CR157","doi-asserted-by":"publisher","first-page":"2771","DOI":"10.1111\/jcmm.12660","volume":"19","author":"L Ambrus","year":"2015","unstructured":"Ambrus, L. et al. Inhibition of TRPC6 by protein kinase C isoforms in cultured human podocytes. J. Cell. Mol. Med. 19, 2771\u20132779 (2015).","journal-title":"J. Cell. Mol. Med."},{"key":"3_CR158","doi-asserted-by":"publisher","first-page":"F674","DOI":"10.1152\/ajprenal.00272.2006","volume":"292","author":"J Eyre","year":"2007","unstructured":"Eyre, J. et al. Statin-sensitive endocytosis of albumin by glomerular podocytes. Am. J. Physiol. Renal Physiol. 292, F674\u2013F681 (2007).","journal-title":"Am. J. Physiol. Renal Physiol."},{"key":"3_CR159","doi-asserted-by":"publisher","first-page":"4548","DOI":"10.1021\/jm2001629","volume":"54","author":"Y Kido","year":"2011","unstructured":"Kido, Y., Matsson, P. & Giacomini, K. M. Profiling of a prescription drug library for potential renal drug\u2013drug interactions mediated by the organic cation transporter 2. J. Med. Chem. 54, 4548\u20134558 (2011).","journal-title":"J. Med. Chem."},{"key":"3_CR160","doi-asserted-by":"publisher","first-page":"933","DOI":"10.1021\/acs.molpharmaceut.5b00821","volume":"13","author":"P Caetano-Pinto","year":"2016","unstructured":"Caetano-Pinto, P. et al. Fluorescence-based transport assays revisited in a human renal proximal tubule cell line. Mol. Pharm. 13, 933\u2013944 (2016).","journal-title":"Mol. Pharm."},{"key":"3_CR161","doi-asserted-by":"publisher","first-page":"2076","DOI":"10.1124\/dmd.107.017723","volume":"35","author":"N Shaik","year":"2007","unstructured":"Shaik, N., Giri, N., Pan, G. & Elmquist, W. F. P-Glycoprotein-mediated active efflux of the anti-HIV1 nucleoside abacavir limits cellular accumulation and brain distribution. Drug Metab. Dispos. 35, 2076\u20132085 (2007).","journal-title":"Drug Metab. Dispos."},{"key":"3_CR162","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1038\/clpt.2011.36","volume":"89","author":"H Kusuhara","year":"2011","unstructured":"Kusuhara, H. et al. Effects of a MATE protein inhibitor, pyrimethamine, on the renal elimination of metformin at oral microdose and at therapeutic dose in healthy subjects. Clin. Pharmacol. Ther. 89, 837\u2013844 (2011).","journal-title":"Clin. Pharmacol. Ther."},{"key":"3_CR163","doi-asserted-by":"publisher","first-page":"341","DOI":"10.1124\/jpet.109.163642","volume":"333","author":"S Ito","year":"2010","unstructured":"Ito, S. et al. Potent and specific inhibition of mMate1-mediated efflux of type I organic cations in the liver and kidney by pyrimethamine. J. Pharmacol. Exp. Ther. 333, 341\u2013350 (2010).","journal-title":"J. Pharmacol. Exp. Ther."},{"key":"3_CR164","doi-asserted-by":"publisher","first-page":"1523","DOI":"10.1046\/j.1523-1755.2000.00314.x","volume":"58","author":"XY Zhai","year":"2000","unstructured":"Zhai, X. Y. et al. Cubilin- and megalin-mediated uptake of albumin in cultured proximal tubule cells of opossum kidney. Kidney Int. 58, 1523\u20131533 (2000).","journal-title":"Kidney Int."},{"key":"3_CR165","doi-asserted-by":"publisher","first-page":"17266","DOI":"10.1074\/jbc.M602614200","volume":"281","author":"E Moreno","year":"2006","unstructured":"Moreno, E. et al. Affinity-defining domains in the Na-Cl cotransporter: a different location for Cl\u2212 and thiazide binding. J. Biol. Chem. 281, 17266\u201317275 (2006).","journal-title":"J. Biol. Chem."},{"key":"3_CR166","first-page":"229","volume":"33","author":"O Andrukhova","year":"2014","unstructured":"Andrukhova, O. et al. FGF23 promotes renal calcium reabsorption through the TRPV5 channel. EMBO J. 33, 229\u2013246 (2014).","journal-title":"EMBO J."},{"key":"3_CR167","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/S0022-3565(24)38241-2","volume":"289","author":"R Masereeuw","year":"1999","unstructured":"Masereeuw, R., Moons, M. M., Toomey, B. H., Russel, F. G. M. & Miller, D. S. Active lucifer yellow secretion in renal proximal tubule: evidence for organic anion transport system crossover. J. Pharmacol. Exp. Ther. 289, 1104\u20131111 (1999).","journal-title":"J. Pharmacol. Exp. Ther."}],"container-title":["Nature Reviews Nephrology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nature.com\/articles\/s41581-018-0003-9","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41581-018-0003-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.nature.com\/articles\/s41581-018-0003-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T17:16:46Z","timestamp":1751563006000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.nature.com\/articles\/s41581-018-0003-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,4,6]]},"references-count":167,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["3"],"URL":"https:\/\/doi.org\/10.1038\/s41581-018-0003-9","relation":{},"ISSN":["1759-5061","1759-507X"],"issn-type":[{"value":"1759-5061","type":"print"},{"value":"1759-507X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,4,6]]},"assertion":[{"value":"6 April 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"M.H.L. holds a research contract with Organovo, Inc. The other authors declare no competing interests.","order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}